Logo

Infectious Disease

News on research and diagnostic development for pathogenic diseases.

Audere Gets FDA Emergency Use Authorization for SARS-CoV-2 At-Home Sample Collection Kit

The kit, developed by digital health firm Audere, is designed for the collection of anterior nasal swab specimens for molecular COVID-19 testing in children and adults.

Labs Home in on SARS-CoV-2 Omicron Variant
Premium

The Association of Public Health Laboratories is directing member labs to focus sequencing efforts on S-gene dropouts for the next week.

Eurofins Technologies Obtains CE Marks for SARS-CoV-2, Flu, RSV RT-PCR Kits

The firm has launched the two molecular diagnostic kits to detect and differentiate between the three respiratory infections in the same PCR run.

InnoTech, MIT Developing Multiplexed Biosensor Platform for SARS-CoV-2 Testing
Premium

Aiming to increase test performance, the developers are integrating separate sensors to detect protein and nucleic acid biomarkers for SARS-CoV-2 in a single platform.

Novacyt SARS-CoV-2 PCR Test Approved in UK Under New Regulations

The UK recently implemented regulations requiring antigen-based and molecular COVID-19 tests to undergo a desktop review in order to be sold in the region.

Nov 23, 2021

Genome Sequencing, EHR Machine Learning Method Detects Unnoticed Hospital Outbreaks
Premium

Nov 23, 2021

Seegene Posts 7 Percent Decline in Q3 Revenues Due to Reduction in COVID Testing

Nov 22, 2021

PathogenDx, Axiology Labs Ink COVID Variant Test Distribution Deal for Africa, Thailand

Nov 19, 2021

Evolution of Dengue Virus Antigens Reflected in Outbreaks in Thailand

Nov 19, 2021

FDA Reclassifies Certain Hepatitis C Diagnostic Tests, Blood Lancets

Nov 18, 2021

Helix, Cue Health Partner on SARS-CoV-2 Variant Sequencing Study

Nov 18, 2021

Inflammatix Receives Additional $12.1M BARDA Funding for MDx Acute Infection Test, System

Nov 17, 2021

Sense Biodetection Raises Additional $15M in Series B Financing Round

Nov 16, 2021

Talis Biomedical Phasing Rollout of SARS-CoV-2 Test, Platform to Reduce Business Risk
Premium

Nov 15, 2021

MiDiagnostics Developing qPCR Platform for SARS-CoV-2 Breath Testing
Premium

Nov 15, 2021

Talis Biomedical Q3 Revenues Plummet on Lower Grant Revenues

Nov 12, 2021

OpGen Q3 Revenues Climb 9 Percent

Nov 11, 2021

Lucira Health Posts $15M in Q3 Revenues

Nov 11, 2021

DiaSorin Q3 Revenues Rise 51 Percent on Luminex Acquisition, Recovery of Non-COVID Test Sales

Nov 10, 2021

Cue Health Revenues up Massively in Q3

Nov 10, 2021

BforCure Gets CE-IVD Mark for Molecular SARS-CoV-2 Test Kit

Nov 10, 2021

LumiraDx Posts Strong Q3 Revenue Gains on Sales of SARS-CoV-2 Testing Products

Nov 9, 2021

RNA Disease Diagnostics Licenses RNA Lateral Flow Tech for At-Home SARS-CoV-2 Test

Nov 9, 2021

Brown University Researchers Develop RNA-Based Breath Test for COVID-19
Premium

Nov 9, 2021

Dotz Ventures Into Molecular Diagnostics Market With SARS-CoV-2 Test
Premium

Breaking News
The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.